• Articaine Inibsa is a modern, highly effective and low-toxic local anesthetic
  • Articaine Inibsa has high local anesthetic activity and duration of pain alleviating effect
  • Anesthetics Inibsa reduce the risk of systemic toxicity of articaine compared to other local anesthetics
Articaine Inibsa is the leader on the market of local anesthetics

Spanish pharmaceutical company Inibsa is a renowned world leader in production of local anesthetics – the production output is more than 250 000 000 carpules per year. Articaine Inibsa is manufactured on the modern high-technology equipment, which guarantees perfect quality and safety of treatment

Articaine 1:100000

100 1.8 ml cartridges

Articaine 1:100000 is used during infiltration, regional, intralegimentary, intraseptal and intrapulpular anesthetic management for anesthetization of traumatizing dental treatment.

Articaine agents with the concentration of epinephrinum 1:100 000 are used during long-lasting and traumatizing dental interventiones, which require prolonged anesthetization and active hemostasis for reduction of bleeding tendency while treatment.

Articaine 1:100000 is local anesthetic, which provides high degree of efficiency and safety.

More details

Articaine 1:200000

100 1.8 ml cartridges

Articaine Inibsa 1:200000 is used during infiltration, regional, intralegimentary, intraseptal and intrapulpular anesthetic management for anesthetization of traumatizing dental intervention. 4% solution of articaine Inibsa 1:200 000 doesn’t yield according to anesthetic activity to 4% solution of articaine Inibsa 1:100 000. In the majority of cases articaine with the concentration of epinephrinum 1:200 000 is applied for anesthetization in dental practice. Low toxicity of articaine and high therapeutic index make it the agent of choice in children, pregnant women and elderly people.

More details

Scandinibsa 3%

100 1.8 ml cartridges

For patients with cardiovascular insufficiency, diabetes mellitus, hypertensive disease, thyrotoxicosis, as well as in patients, who are under medical treatment with antidepressant medications, special anesthetic Scandinibsa (mepivacaine hydrochloride 3%) has been developed without vasoconstrictor. Scandinibsa has no vasorelaxant action, which makes it the agent of choice in patients with hypersensitivity to vasoconstrictors. Minimal vasodilatory effect makes it possible to use this anesthetic reduce to a minimum impacts to heart-vascular system.

More details

Carpule injector ARTIJECT with anesthetics Inibsa

ARTIJECT is a single-use syringe-injector – standard of infection safety in dentology. Joint development of Inibsa Dental and RusPharm.
More details
Standard of injection safety
ARTIJECT is a single-use syringe-injector – standard of infection control when performing local anesthesia.
Standard of injection safety
Anesthetics Inibsa – standard of glass carpules with local anesthetics, which include the following main characteristics: sterility of anesthetic solution, accurate dose of anesthetic, accurate dose of vasoconstrictor.
Standard of injection safety
Single-use of carpule needles are the integral part of this system, aimed at the provision of efficient and safe local anesthesia. The diameter of carpule needle doesn’t exceed 0.3 – 0.4 mm, which significantly reduces sensation of pain and decreases the risk of additional injuries of mucous coat.
STANDARD OF INJECTION SAFETY

Inibsa and ARTIJECT develop and create new technologies of local anesthesia, where safe and proper performance of this procedure can be guaranteed due to introduction of the standard of injection safety into dental practice, which consists in use of three single-use sterile components